Experience with heart transplantation in children

Area of Science:

• Cardiology
• Pediatric Surgery
• Immunology

Background:

• Orthotopic heart transplantation is a critical treatment for end-stage heart disease in children.
• The University of Pittsburgh performed 200 heart transplants between 1981 and 1986, including 14 in pediatric patients.

Purpose of the Study:

• To review the outcomes of pediatric heart transplantation, including indications, complications, and long-term results.
• To analyze the challenges associated with immunosuppression and allograft rejection in young recipients.

Main Methods:

• Retrospective analysis of 14 pediatric heart transplant cases (ages 2-16) performed between March 1981 and March 1986.
• Detailed review of patient records, including transplant indications, surgical procedures, immunosuppressive regimens (prednisone, cyclosporine, antithymocyte globulin), and postoperative outcomes.

Main Results:

• Three early postoperative deaths occurred due to intracranial bleeding, Pseudomonas mediastinitis, and ischemic injury.
• Common early complications included reversible renal failure, hypertension, and seizures.
• All surviving patients experienced significant rejection episodes, with two deaths from acute and chronic rejection and one requiring retransplantation due to chronic rejection.

Conclusions:

• Pediatric heart transplantation presents significant early and late challenges, primarily related to postoperative complications, allograft rejection, and immunosuppression side effects.
• Long-term survival is heavily influenced by the management of rejection and the adverse effects of medications like cyclosporine and corticosteroids.
• Further research into optimizing immunosuppression protocols and managing rejection is essential for improving outcomes in pediatric heart transplant recipients.